Alnylam wins prestigious prix galien award for best biotechnology product with first-ever approved rnai therapeutic, onpattro® (patisiran)

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today announced it has won the 2020 prix galien usa award for best biotechnology product for onpattro® (patisiran). the award, which recognizes excellence in scientific innovation that improves the state of human health, was presented by the galien foundation during the 50th annual prix galien usa awards ceremony yesterday. “we are thrilled to receive this prestigious recognit
ALNY Ratings Summary
ALNY Quant Ranking